Home / News
 

17 June 2008 05:40 pm

West Malling, UK, 17 June 2008: Phoqus Pharmaceuticals plc (AIM: PQS) (“Phoqus” or the “Company”), the speciality pharmaceutical company, announces that the results of the Phase 2 clinical trial of Chronocort #004 were presented on 15 June by the NIH at the Endocrine Society meeting in San Francisco.
 


03 April 2008 10:04 am

A study by Crouch, et al. from the United Kingdom is the first study to evaluate genital sensitivity and sexual function in women with a history of congenital adrenal hyperplasia. The affects of feminizing genitoplasty on genital sensitivity have never been objectively evaluated until this study was performed.
 


Phoqus Pharmaceuticals Announces Positive Results from a Phase II study of its Novel Cortisol Replacement Therapy, Chronocort®
03 March 2008 01:09 pm

Primary and secondary endpoints successfully demonstrate clinical proof of concept in patients with Congenital Adrenal Hyperplasia. Company plans to proceed to a Phase III pivotal trial.
 


09 February 2008 09:37 am

A German woman who was mistakenly raised as a boy won a lawsuit against the surgeon who turned her into a man as a teenager, a court said on Thursday.
 


30 November 2007 02:05 pm

Bristol-Myers Squibb, manufacturers of the fludrocortisone tablet Florinef®, recently announced that due to production problems they will be changing the formula that will affect how the drug is stored. CAH Support Group Chairman, Sue Elford, contacted BMS to find out why.
 


28 November 2007 08:44 am

Phoqus Pharmaceuticals PLC said the open-label trial of Chronocort, its treatment for congenital adrenal hyperplasia, is progressing well and it expects to start late-stage clinical studies in the first half of 2008.
 

MORE NEWS
  • National Institutes of Health (“NIH”) presents Chronocort® Phase 2 clinical trial results at ENDO in San Francisco
  • CAH support group AGM
  • Sexual Function and Genital Sensitivity Following Feminizing Genitoplasty for Congenital Adrenal Hyperplasia
  • Positive results from Chronocort®
  • German woman wins case over sex change operation
  • Florinef® to restrict patients ability to live a normal life!
  • Phoqus Pharma says Chronocort open-label trial progressing well
  • Impaired Sexual and Reproductive Outcomes in Women with Classical Forms of Congenital Adrenal Hyperplasia
  • Drug Availability Announcement
  • Phoqus agrees 2.5 mln stg loan with Oxford Finance
  • HOME |  THE SUPPORT GROUP |  NEWS |  FAQS |  FORUMS |  CONTACT US |  DISCLAIMER
    'Living with CAH' is the working title of Climb CAH Support Group, a sub-group of Climb Registered Charity No. 1089588 | Design & Development by tonicmedia | DHTML Menu by Milonic